Study On The Optimization Of Diversification Strategy Of Anhui Anke Biotechnology(Group)Co.,Ltd.

With the steady development of China's economy and the increasing demand for medcine,the pharmaceutical industry is growing rapidly.With more and more policy support for pharmaceutical enterprises,especially for biopharmaceutical enterprises,biopharmaceutical enterprises are facing unprecedented opportunities for development.Many enterprises have seized the opportunity to achieve growth through diversification strategy.Anhui Anke Biotechnology(Group)Co.,Ltd.is a relatively influential biopharmaceutical enterprise group in China.Since it was founded in 1994,it has maintained growth through diversification strategy.In 2009,the Group successfully listed on the GEM.and then it had become a large pharmaceutical group covering the fields of genetic engineering medicines,biological testing,biological raw materials medicines Chinese patent medicine and chemical medicine,through a series of diversified strategic mergers and acquisitions.In the future,it is very important for the Group that how to achieve sustainable growth through diversification.This paper combines diversification theory with practice,surveys and statistics,interviews senior executives,and through a series of analysis and demonstration,helps the Group to formulate the optimization scheme of diversification strategy,which is of great significance in the future of enterprises.In addition,many pharmaceutical enterprises are implementing diversification strategy at present.I believe this article isvery important for the formulation of these pharmaceutical enterprises' strategies.The main contents of this paper are as follows.Firstly,this paper synthesizes many theories and literature about diversification strategy,including the classification of diversification strategy,the motivation of diversification strategy,the performance of diversification strategy and the risk of diversification strategy.At the same time,the research on diversification strategy by scholars is reviewed,and four kinds of strategic analysis tools are introduced:PEST method,SWOT analysis,BCG Matrix and five-force model analysis.Secondly,this paper makes a performance analysis of the important activities in the diversification process of Anhui Anke Biotechnology(Group)Co.,Ltd.At the same time,the course of diversification strategy is summarized,and the experience and shortcomings are summarized.It is very important for the Group to formulate the optimization scheme of diversification strategy,because of the lack of systematic planning in the implementation of diversification strategy?Thirdly,this paper combines the external and internal environment of Anhui Anke Biotechnology(Group)Co.,Ltd.and defines the mission,vision and strategic objectives.The mission is to strive for human health and to be a provider of health products or services.The vision is to become a leader in children's medicines,liver medicines and anti-cancer medicines or services in the biopharmaceutical industry.The strategic goal is to become an enterprise with operating income of over 17 billion and net profit of over 2.5 billionw ith 5-10 years' efforts,which is with great influence in the field of large health industry.This paper also optimizes the strategic layout,initially establishes the concept of one-two-three layout,and carries out the layout around the three major market areas of children's medicines,anti-cancer medicines and liver diseases medicines.The main conclusions of this paper are as follows.It can help the Group achieve sustained growth,which is focusing on core competitiveness and actively pursuing limited diversification strategies.The Group eventually become alarge group company covering the detection and treatment of diseases with strong competitiveness in the field of large health industry.Finally,this paper formulates implementation measures from the aspects of cultivating core competitiveness and financing measures,aiming at the strategic objectives of diversification.In addition,the safeguard measures are put forward in detail from the perspectives of human resources,organization,finance,culture,marketing and informatization.